
LSX Nordic Congress
April 1, 2019/by Beth Zalcman
NLSDays 2019
March 17, 2019/by Beth Zalcman
7th Annual HealthTech Investment Forum
March 14, 2019/by Beth Zalcman
19th Annual Biotech in Europe Forum
February 28, 2019/by Beth Zalcman
RESI Vienna
February 7, 2019/by Beth Zalcman
5th Annual Immuno-Oncology BD&L Investment Forum
February 6, 2019/by Beth Zalcman
NIH and VC Funding; Growth Engines for the Life Science Industry NIH and VC Funding
January 28, 2019/by Ayal Ronen
CARB-X to DRIVe: Building Novel Public Private Partnership to Foster Disruptive Innovation
January 28, 2019/by Ayal Ronen
A Discussion with Matt Portnoy, Head of a $1B Government Seed Fund
January 28, 2019/by Ayal Ronen
The NIA SBIR/STTR Programs, Funding Opportunities, and Application Tips from NIH Program Officers
January 28, 2019/by Ayal Ronen
SBIR/STTR and the NIDDK: Overview and R&D Interests
January 28, 2019/by Ayal Ronen
Diassess’s Successful Non-Dilutive Funding Journey
January 28, 2019/by Ayal RonenSearch
Recent Posts
BIO Partnering for Oncology, May 28-31, 2026, Chicago, USAApril 15, 2026 - 8:22 am
LSX Nordic Congress, May 19-20, 2026, Copenhagen, DenmarkApril 15, 2026 - 8:15 am
AngloNordic, April 23, 2026, LondonMarch 19, 2026 - 12:29 pm
Despite Delays, NIH Grants Deliver Remarkable Economic and Scientific ValueMarch 16, 2026 - 7:05 am
BioTrinity, April 14-15, 2026, LondonMarch 15, 2026 - 11:02 am
